SEARCH

SEARCH BY CITATION

References

  • 1
    Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba, II, Alonso de Ruiz P, Aristi Urista G, Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 34964.
  • 2
    Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 16776.
  • 3
    Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev 2003; 12: 1524.
  • 4
    Zatonski W, La Vecchia C, Levi F, Negri E, Lucchini F. Descriptive epidemiology of gall-bladder cancer in Europe. J Cancer Res Clin Oncol 1993; 119: 16571.
  • 5
    De Aretxabala X, Riedeman P, Burgos L, Roa I, Araya JC, Echeverria X, Toledo MI, Charles M, Espinoza O, Wenzel C. [ Gallbladder cancer. Case-control study]. Rev Med Chil 1995; 123: 58186.
  • 6
    Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, Jain M, Przewozniak K, Baghurst P, Moerman CJ, Simard A, Howe GR, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997; 89: 11328.
  • 7
    WaterhouseJ, MuirC, CorreaP, PowellJ, eds. Cancer incidence in five continents, vol. 3. IARC scientific publications no. 15. Lyon: IARC, 1976.
  • 8
    WaterhouseJ, MuirC, ShanmugaratnamK, PowellJ, PeachamD, WhelanS, eds. Cancer incidence in five continents, vol. 4. IARC scientific publications no. 42. Lyon: IARC, 1982.
  • 9
    MuirC, WaterhouseJ, MackT, PowellJ, WhelanS, eds. Cancer incidence in five continents, vol. 5. IARC scientific publications no. 88. Lyon: IARC, 1987.
  • 10
    ParkinDM, MuirC, WhelanS, GaoYT, FerleyJ, PowellJ, eds. Cancer incidence in five continents, vol. 6. IARC scientific publications no. 120. Lyon: IARC, 1992.
  • 11
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in five continents, vol. 7. IARC scientific publications no. 143. Lyon: IARC, 1997.
  • 12
    ParkinDM, WhelanSL, FerlayJ, TeppoL, ThomasDB, eds. Cancer incidence in five continents, vol. 8. IARC scientific publications no. 155. Lyon: IARC, 2002.
  • 13
    WHO. International classification of diseases (ICD-7). Geneva: WHO, 1955.
  • 14
    WHO. International classification of diseases (ICD-8). Geneva: WHO, 1967.
  • 15
    WHO. International classification of diseases (ICD-9). Geneva: WHO, 1977.
  • 16
    WHO. International classification of disease (ICD-10). Geneva: WHO, 1992.
  • 17
    Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, Stimec B, Lehn N, Lowenfels AB, Lohr M. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95: 194653.
  • 18
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 162538.
  • 19
    Caygill CP, Hill MJ, Braddick M, Sharp JC. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 1994; 343: 834.
  • 20
    Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen JH, Fraumeni JF,Jr. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 1999; 79: 6404.
  • 21
    Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA 1983; 250: 23236.
  • 22
    Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000; 95: 7847.
    Direct Link:
  • 23
    Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994; 3: 20912.
  • 24
    Gallus S, Negri E, Chatenoud L, Bosetti C, Franceschi S, La Vecchia C. Post-menopausal hormonal therapy and gallbladder cancer risk. Int J Cancer 2002; 99: 7623.
  • 25
    Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 16008.
  • 26
    Hemminki K, Li X. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut 2003; 52: 5926.
  • 27
    Kato K, Akai S, Tominaga S, Kato I. A case-control study of biliary tract cancer in Niigata Prefecture, Japan. Jpn J Cancer Res 1989; 80: 9328.
  • 28
    Khan ZR, Neugut AI, Ahsan H, Chabot JA. Risk factors for biliary tract cancers. Am J Gastroenterol 1999; 94: 14952.
    Direct Link:
  • 29
    Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Suzuki Y, Ohmori K, Nishino Y, Tsuji I. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 14857.
  • 30
    Lambe M, Trichopoulos D, Hsieh CC, Ekbom A, Adami HO, Pavia M. Parity and cancers of the gallbladder and the extrahepatic bile ducts. Int J Cancer 1993; 54: 9414.
  • 31
    Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst 1985; 75: 7780.
  • 32
    Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellof L. Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol 1989; 18: 504.
  • 33
    Maringhini A, Moreau JA, Melton LJ,III, Hench VS, Zinsmeister AR, DiMagno EP. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med 1987; 107: 305.
  • 34
    Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, Kamiya S, Naito Z, Fox JG. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002; 93: 8427.
  • 35
    Moerman CJ, Lagerwaard FJ, Bueno de Mesquita HB, van Dalen A, van Leeuwen MS, Schrover PA. Gallstone size and the risk of gallbladder cancer. Scand J Gastroenterol 1993; 28: 4826.
  • 36
    Moerman CJ, Berns MP, Bueno de Mesquita HB, Runia S. Reproductive history and cancer of the biliary tract in women. Int J Cancer 1994; 57: 14653.
  • 37
    Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994; 30A: 34450.
  • 38
    Murata H, Tsuji S, Tsujii M, Fu HY, Tanimura H, Tsujimoto M, Matsuura N, Kawano S, Hori M. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther 2004; 20( Suppl 1): 904.
  • 39
    Nath G, Singh H, Shukla VK. Chronic typhoid carriage and carcinoma of the gallbladder 211. Eur J Cancer Prev 1997; 6: 5579.
  • 40
    Nervi F, Duarte I, Gomez G, Rodriguez G, Del Pino G, Ferrerio O, Covarrubias C, Valdivieso V, Torres MI, Urzua A. Frequency of gallbladder cancer in Chile, a high-risk area. Int J Cancer 1988; 41: 65760.
  • 41
    Okamoto M, Okamoto H, Kitahara F, Kobayashi K, Karikome K, Miura K, Matsumoto Y, Fujino MA. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am J Gastroenterol 1999; 94: 44650.
    Direct Link:
  • 42
    Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 2003; 12: 26972.
  • 43
    Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF,Jr. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004; 15: 3543.
  • 44
    Serra I, Yamamoto M, Calvo A, Cavada G, Baez S, Endoh K, Watanabe H, Tajima K. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer 2002; 102: 40711.
  • 45
    Shukla VK, Singh H, Pandey M, Upadhyay SK, Nath G. Carcinoma of the gallbladder—is it a sequel of typhoid? Dig Dis Sci 2000; 45: 9003.
  • 46
    Singh H, Pandey M, Shukla VK. Salmonella carrier state, chronic bacterial infection and gallbladder carcinogenesis. Eur J Cancer Prev 1996; 5: 144.
  • 47
    Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, Polansky M, Berlin JA. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995; 76: 174756.
  • 48
    Tavani A, Negri E, La Vecchia C. Menstrual and reproductive factors and biliary tract cancers. Eur J Cancer Prev 1996; 5: 2417.
  • 49
    WHO. Combined oral contraceptives and gallbladder cancer. The WHO collaborative study of neoplasia and steroid contraceptives. Int J Epidemiol 1989; 18: 30914.
  • 50
    Yagyu K, Lin Y, Obata Y, Kikuchi S, Ishibashi T, Kurosawa M, Inaba Y, Tamakoshi A; JACC Study Group. Bowel movement frequency, medical history and the risk of gallbladder cancer death: a cohort study in Japan. Cancer Sci 2004; 95: 6748.
  • 51
    Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 130.
  • 52
    Rizvi TJ, Zuberi SJ. Risk factors for gall bladder cancer in Karachi. J Ayub Med Coll Abbottabad 2003; 15: 1618.
  • 53
    Paltoo DN, Chu KC. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992–1999. Public Health Rep 2004; 119: 44351.
  • 54
    Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, Welty TK. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002; 35: 150712.
  • 55
    Miquel JF, Covarrubias C, Villaroel L, Mingrone G, Greco AV, Puglielli L, Carvallo P, Marshall G, Del Pino G, Nervi F. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 93746.
  • 56
    Brasca AP, Pezzotto SM, Berli D, Villavicencio R, Fay O, Gianguzzo MP, Poletto L. Epidemiology of gallstone disease in Argentina: prevalences in the general population and European descendants. Dig Dis Sci 2000; 45: 23928.
  • 57
    Gonzalez VC, Rivera MD, Arredondo PB, Martinez DS, Gonzalez Villalpando ME, Haffner SM, Stern MP. High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. Arch Med Res 1997; 28: 5437.
  • 58
    Moro PL, Checkley W, Gilman RH, Cabrera L, Lescano AG, Bonilla JJ, Silva B. Gallstone disease in Peruvian coastal natives and highland migrants. Gut 2000; 46: 56973.
  • 59
    Sugimoto M, Abei T, Kameda H. A clinical study on gallstones in Bolivia. Jpn J Med 1983; 22: 904.
  • 60
    Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999; 27: 17.
  • 61
    Caroli-Bosc FX, Deveau C, Harris A, Delabre B, Peten EP, Hastier P, Sgro E, Caroli-Bosc C, Stoia M, Demarquay JF, Dumas R, Coussement A, et al. Prevalence of cholelithiasis: results of an epidemiologic investigation in Vidauban, southeast France. General Practitioner's Group of Vidauban. Dig Dis Sci 1999; 44: 13229.
  • 62
    Domellof L, Lowenfels AB, Sipponen P. Prevalence of gallstones in Finland: an autopsy study in the Helsinki area. Scand J Gastroenterol 1984; 19: 7614.
  • 63
    Bates T, Harrison M, Lowe D, Lawson C, Padley N. Longitudinal study of gall stone prevalence at necropsy. Gut 1992; 33: 1037.
  • 64
    Borch K, Jonsson KA, Zdolsek JM, Halldestam I, Kullman E. Prevalence of gallstone disease in a Swedish population sample. Relations to occupation, childbirth, health status, life style, medications, and blood lipids. Scand J Gastroenterol 1998; 33: 121925.
  • 65
    Acalovschi M, Pascu M, Iobagiu S, Petrescu M, Olinici CD, Ban A, Dumitrascu D. Increasing gallstone prevalence and cholecystectomy rate in a large Romanian town. A necropsy study. Dig Dis Sci 1995; 40: 25826.
  • 66
    Vitetta L, Sali A, Chou ST, Fleming H, Little P, Elzarka A. Gallstones at autopsy and cholecystectomy: a comparative study. Aust N Z J Surg 1988; 58: 5618.
  • 67
    Kapoor VK, McMichael AJ. Gallbladder cancer: an ‘Indian’ disease. Natl Med J India 2003; 16: 20913.
  • 68
    Brett M, Barker DJ. The world distribution of gallstones. Int J Epidemiol 1976; 5: 33541.
  • 69
    La Vecchia C, Negri E, D'Avanzo B, Franceschi S, Boyle P. Risk factors for gallstone disease requiring surgery. Int J Epidemiol 1991; 20: 20915.
  • 70
    Wistuba, II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 2004; 4: 695706.
  • 71
    Nuzzo G, Clemente G, Cadeddu F, Ardito F, Ricci R, Vecchio FM. Papillary carcinoma of the gallbladder and anomalous pancreatico-biliary junction. Report of three cases and review of the literature. Hepatogastroenterology 2005; 52: 10348.
  • 72
    Kimura K, Ohto M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, Ebara M, Matsutani S, Okuda K. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 1985; 89: 125865.
  • 73
    Kosters A, Jirsa M, Groen AK. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta 2003; 1637: 119.
  • 74
    Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev 2004; 17: 54052.
  • 75
    Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, Fang YY. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 2005; 5: 3141.
  • 76
    Chianale J, Del Pino G, Nervi F. Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area. Int J Cancer 1990; 46: 11313.
  • 77
    Wood R, Fraser LA, Brewster DH, Garden OJ. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer 2003; 39: 20806.
  • 78
    Diehl AK, Beral V. Cholecystectomy and changing mortality from gallbladder cancer. Lancet 1981; 2: 1879.